McKnight’s Senior Living April 8, 2024
Haymarket Media

(HealthDay News) — For hospitalized patients with cancer, immersive virtual reality (VR) distraction therapy is associated with a greater reduction in pain compared with an active control, according to a study published online April 8 in Cancer.

Hunter Groninger, MD, from MedStar Health Research Institute in Hyattsville, MD, and colleagues conducted a prospective randomized controlled trial comparing VR to an active control to mitigate moderate-to-severe cancer disease and treatment-related pain among 128 adult hospitalized patients with cancer. Participants were randomly assigned to 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery distraction therapy. In terms of age, sex, race, presence of metastatic disease, concurrent pain specialist consultation, and baseline opioid use, participants in the two...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Metaverse/VR, Provider, Technology
Related Articles:
Using Virtual Reality to Improve Communication and Collaboration in Nursing Teams
FDA Launches ‘Home as a Health Care Hub’ Initiative With Equity Focus
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
Old Dominion University, HaptX, Georgia Tech receive grant for VR for the visually impaired
FDA initiative puts AR/VR at heart of home health drive

Share This Article